Tag: LSH

InhaleRx ASX IRX Lifespot Health Medihale inhaler

Lifespot Health rebrands to InhaleRx, pushes development of Medihale inhaler

Australian medicinal cannabis device company Lifespot Health (ASX: LSH) has officially changed its name to InhaleRx (ASX: IRX), with the change to take effect on Wednesday. The new moniker has been...
Lifespot Health ASX LSH Medihale medical cannabis July 2021 Medihale inhaler

Lifespot Health reveals new R&D strategy amid board shake-up

Medical cannabis device developer Lifespot Health (ASX: LSH) has announced a revised research and development strategy prioritising US Food and Drug Administration (FDA) approval of its Medihale canna...
Lifespot Health ASX LSH Dr Andrew Saich Darryl Davies board directors

Lifespot Health appoints cannabis specialists to board of directors

Australian medicinal cannabis device company Lifespot Health (ASX: LSH) has appointed two non-executive directors to its board to help execute a strategy of delivering innovative medication systems an...
Lifespot Health ASX LSH Ela Capital Canadian advisor medical cannabis Terrascend Medihale

Lifespot Health appoints Canadian advisor to take medical cannabis technology to the world stage

Medical cannabis device developer Lifespot Health (ASX: LSH) has appointed Canadian investment fund Ela Capital as its corporate advisor to assist with the commercialisation of its technologies in the...
Lifespot Health ASX LSH Medihale sealed pod inhaler medical cannabis market Australia

Lifespot Health launches Medihale sealed pod inhaler to medical cannabis market in Australian first

Lifespot Health (ASX: LSH) has achieved first sales of its medical cannabis inhaler to Australian patients under the Therapeutic Goods Administration’s (TGA) Special Access Scheme (SAS). The compan...
Lifespot Health LSH ASX revenue Medihale medicinal cannabis inhaler device December 2020

Lifespot Health generates revenue from Medihale medicinal cannabis inhaler device

Inhaled medical cannabis device developer Lifespot Health (ASX: LSH) ended the December 2020 quarter with its first revenue from sales of its Medihale inhaler device. Sales of the device generated ...
Lifespot Health ASX LSH Ela Capital Cannafund Medihale vape cannabis

Lifespot Health reveals investment from major Canadian cannabis fund

Lifespot Health (ASX: LSH) has announced a significant investment by major Canadian cannabis investment fund Ela Capital, marking a great achievement for the Australian cannabis industry as well as pr...
Lifespot Health medical cannabis vape pen trials Matthew Golden

Medical cannabis expert boosts Lifespot Health leadership ahead of vape pen trials

Lifespot Health (ASX: LSH) is further enhancing its leadership team and topping up cash reserves as it advances the development of its medical cannabis inhaler device program it claims will “significa...
Lifespot Health ASX LSH Israel medical cannabis Seng Vital vaporiser

Lifespot Health edges into Israel’s medical cannabis space with Seng Vital vaporiser

Digital health provider Lifespot Health (ASX: LSH) is edging into Israel’s medical cannabis market after entering discussions to have its Seng Vital vaporiser, which comprises the certified BodyTel so...
Lifespot Health ASX LSH self-managed biosensor system combat metabolic syndrome

Lifespot Health creates self-managed biosensor system to combat metabolic syndrome and diabetes

Medical diagnostics and technology company Lifespot Health (ASX: LSH) has announced the highly-anticipated launch of its patient self-management system for metabolic syndrome and diabetes. The syst...

RECENT POSTS

STOCK SUMMARY

FOLLOW US

HOT TOPICS

TRENDING POSTS